Stryker launches new coil shape for new possibilities in aneurysm treatment

Stryker announced the 510k clearance of the Target Tetra Detachable Coil, the latest addition to the market-leading Target platform. The Target Tetra Detachable Coil combines a new tetrahedral shape and softness level, specifically designed to treat small aneurysms. 

The delicate nature of small aneurysms makes the use of soft coils extremely important but historically, soft coils have not had strong shape stability. The Target Tetra Detachable Coil is unique because the tetrahedral shape is designed to frame small aneurysms with ease, while being the softest coil in the Target family. 

“Target Tetra is very high performing and easy to use because the tetrahedral shape allows it to stay inside the aneurysm with minimal microcatheter manipulation. This will allow physicians of all skill sets to feel more confident when treating small aneurysms, which will help many patients!” said Satoshi Tateshima, MD, DMSc, interventional neuroradiologist, Los Angeles, CA.

“The Target platform has a proven legacy, and the launch of Target Tetra reflects our commitment to partnering with our customers to develop innovative products,” said Mark Paul, President of Stryker’s Neurovascular Division. “I am excited to add Target Tetra to our portfolio because it provides a new option for patients with smaller, more difficult-to-treat aneurysms, and will ultimately help physicians treat more aneurysm patients.”